Clinical Trials Logo

Clinical Trial Summary

Ageing is the primary risk factor for most chronic diseases including type 2 diabetes mellitus. Sarcopenia and muscular mitochondrial dysfunction with aging are crucial mechanisms leading to decreased exercise tolerance and worsened insulin sensitivity. Thus, metabolic disease and frailty, which limits physical mobility as well as quality of life, share common cellular mechanisms.

The investigators will test the hypothesis that a combination of normobaric hypoxia and exercise training elicits a synergistic effect on age-associated metabolic skeletal muscle dysfunction and the investigators will address the molecular mechanisms. In a randomized clinical study, the investigators will compare normoxic and hypoxic training conditions in elderly subjects. Outcome measures will focus on whole body insulin sensitivity and mitochondrial responses in skeletal muscle before and after the 8-week training intervention.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02196623
Study type Interventional
Source Hannover Medical School
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date January 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04168424 - Validation of the English Version of the FIMA Questionnaire
Completed NCT02816580 - Biological MArkers of FRAilty in Elderly Subjects N/A